Natsuki Takaha
Overview
Explore the profile of Natsuki Takaha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
678
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hongo F, Ueda T, Takaha N, Tamada S, Nakatani T, Miki T, et al.
Int J Urol
. 2022 Oct;
30(2):176-180.
PMID: 36305687
Background: IMA901 is the first therapeutic vaccine for renal cell cancer (RCC). It contains multiple tumor-associated peptides (TUMAPs) that are naturally present in human cancers. Methods: In a phase I/II...
2.
Naya Y, Takaha N, Hayashi I, Mori M, Date S, Ukimura O
Asian J Endosc Surg
. 2022 Jul;
16(1):143-146.
PMID: 35778988
We previously reported that probe-based confocal laser endomicroscopy using acrinol can depict cancerous nuclei. The objective of this study was to confirm the safety of acrinol in patients. For all...
3.
Naya Y, Mikami K, Takaha N, Inoue Y, Fujihara A, Kanazawa M, et al.
Medicine (Baltimore)
. 2018 Oct;
97(42):e12740.
PMID: 30334959
Purpose: The objective of this study was to evaluate the efficacy, defined by the 3-year tumor recurrence-free survival rate, of intravesical chemotherapy using pirarubicin (THP) in patients with low or...
4.
Naya Y, Takaha N, Okubo T, Shiota K, Hayashi I, Mori M, et al.
J Endourol Case Rep
. 2018 Mar;
4(1):25-27.
PMID: 29503871
Cystoscopy using white light is a standard procedure for diagnosing bladder cancer; however, white light can result in missed lesions that are present, but not visible, such as in cases...
5.
Hongo F, Takaha N, Oishi M, Ueda T, Nakamura T, Naitoh Y, et al.
Urol Oncol
. 2014 Dec;
32(8):1240-6.
PMID: 25443276
Background: In renal cell carcinoma (RCC), the prediction of metastasis via tumor prognostic markers remains a major problem. The objective of our study was to evaluate the efficacy of cyclin-dependent...
6.
Toiyama D, Takaha N, Shinnoh M, Ueda T, Kimura Y, Nakamura T, et al.
Mol Clin Oncol
. 2014 Mar;
1(1):69-74.
PMID: 24649125
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is endogenously expressed in immune cells and contributes to immunosurveillance for cancer. TRAIL induces apoptosis preferentially in various cancer cells, including renal cell carcinoma...
7.
Takata R, Matsuda K, Sugimura J, Obara W, Fujioka T, Okihara K, et al.
J Hum Genet
. 2012 Nov;
58(1):21-6.
PMID: 23151678
Tamsulosin hydrochloride is one of the most potent drugs for treatment of benign prostatic hyperplasia (BPH), however, the efficacy of tamsulosin hydrochloride varies among individuals. In this study, we measured...
8.
Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, Szczylik C, et al.
Nat Med
. 2012 Jul;
18(8):1254-61.
PMID: 22842478
IMA901 is the first therapeutic vaccine for renal cell cancer (RCC) consisting of multiple tumor-associated peptides (TUMAPs) confirmed to be naturally presented in human cancer tissue. We treated a total...
9.
Takaha N, Sowa Y, Takeuchi I, Hongo F, Kawauchi A, Miki T
J Urol
. 2012 Apr;
187(6):2215-22.
PMID: 22503056
Purpose: Although molecular targeted therapy has improved the clinical outcome of metastatic renal cell carcinoma, a complete response is rare and there are various side effects. Identifying novel target molecules...
10.
Takaha N, Nakanishi H, Kimura Y, Hongo F, Kamoi K, Kawauchi A, et al.
Int J Oncol
. 2012 Feb;
40(5):1441-6.
PMID: 22344395
We previously reported that cationic multilamellar liposome containing the human interferon-β (huIFN-β) gene (IAB-1) demonstrated significant cytotoxic effect in the NC65 human renal cell carcinoma (RCC) cell line. In this...